Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GIGA
San Carlos, California, United States
- Ownership
- Private
- Employees
- ~39
- Development stage
- Other
01
Overview
GigaGen is a U.S. antibody therapeutics company and subsidiary of Grifols focused on discovering and developing monoclonal and recombinant polyclonal antibody drugs. The company uses single-cell immune repertoire technologies to capture naturally occurring human antibody responses and recreate them as engineered therapeutic libraries. Its pipeline includes an anti-CTLA-4 oncology antibody and recombinant polyclonal antibody candidates for infectious disease indications such as hepatitis B and COVID-19. GigaGen also applies machine learning to antibody discovery and has demonstrated GMP manufacturing for recombinant hyperimmune products. The company operates as an acquired but active biotechnology subsidiary within Grifols' innovation portfolio.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyRecombinant proteinBiologic
- Industry
- Biotech
02
Partnerships
GrifolsU.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear DefenseNational Cancer InstituteProteoNic
Beyond the preview
Go deeper on GIGA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GIGA.